The objective of the Foundation is in part to maintain and expand the activities of Lundbeck as well as of the Foundation’s other subsidiaries and portfolio companies through active value-adding ownership, and in part to provide grants for scientific research of the highest international quality in order to make a significant difference to human health and life. Grants are given based on external peer review and independently of Lundbeck.
In addition to its ownership of Lundbeck, the Foundation also has controlling shareholdings in ALK and Falck and manages its portfolio of financial investments through Lundbeckfond Invest and Lundbeckfond Ventures. The Foundation annually grants between DKK 400-500 million to support medical research and educational and communication activities.
The Lundbeck Foundation has in recent years increased its focus on personal grants. The Foundation’s latest initiative, Lundbeckfond Emerge, works to accelerate the commercialization of early scientific projects by way of investment and active project participation.
For further information about the Foundation, please visit www.lundbeckfonden.com.